Susquehanna International Group, LLP Mersana Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 74,809 shares of MRSN stock, worth $165,327. This represents 0.0% of its overall portfolio holdings.

Number of Shares

74,809

Previous 108,859 31.28%

Holding current value

$165,327

Previous $218,000 35.32%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.23 - $2.25 $41,881 - $76,612	-34,050 Reduced 31.28%	74,809 $141,000
Q2 2024 Aug 15, 2024	BUY	$2.0 - $4.45 $26,754 - $59,527	13,377 Added 14.01%	108,859 $218,000
Q1 2024 May 07, 2024	SELL	$2.16 - $5.94 $123,765 - $340,356	-57,299 Reduced 37.5%	95,482 $427,000
Q4 2023 Feb 14, 2024	SELL	$1.11 - $2.34 $31,158 - $65,686	-28,071 Reduced 15.52%	152,781 $354,000
Q3 2023 Nov 14, 2023	SELL	$1.06 - $3.91 $118,152 - $435,828	-111,465 Reduced 38.13%	180,852 $229,000
Q2 2023 Aug 11, 2023	BUY	$3.08 - $9.55 $55,535 - $172,196	18,031 Added 6.57%	292,317 $961,000
Q1 2023 May 16, 2023	BUY	$4.0 - $7.02 $937,336 - $1.65 Million	234,334 Added 586.54%	274,286 $1.13 Million
Q4 2022 Feb 14, 2023	SELL	$5.65 - $7.86 $352,915 - $490,959	-62,463 Reduced 60.99%	39,952 $234,000
Q3 2022 Nov 14, 2022	BUY	$4.63 - $8.0 $385,780 - $666,576	83,322 Added 436.4%	102,415 $692,000
Q2 2022 Aug 15, 2022	SELL	$2.84 - $5.0 $439,328 - $773,465	-154,693 Reduced 89.01%	19,093 $88,000
Q1 2022 May 16, 2022	BUY	$3.74 - $6.63 $193,840 - $343,626	51,829 Added 42.5%	173,786 $693,000
Q4 2021 Feb 14, 2022	BUY	$5.48 - $9.86 $154,623 - $278,209	28,216 Added 30.1%	121,957 $759,000
Q3 2021 Nov 15, 2021	SELL	$8.56 - $14.47 $144,330 - $243,978	-16,861 Reduced 15.24%	93,741 $884,000
Q2 2021 Aug 11, 2021	SELL	$13.28 - $18.07 $275,918 - $375,440	-20,777 Reduced 15.81%	110,602 $1.5 Million
Q1 2021 May 17, 2021	BUY	$15.31 - $26.52 $1.81 Million - $3.14 Million	118,222 Added 898.55%	131,379 $2.13 Million
Q4 2020 Feb 16, 2021	SELL	$16.84 - $27.59 $946,340 - $1.55 Million	-56,196 Reduced 81.03%	13,157 $350,000
Q3 2020 Nov 16, 2020	BUY	$16.2 - $25.7 $714,241 - $1.13 Million	44,089 Added 174.51%	69,353 $1.29 Million
Q2 2020 Aug 14, 2020	BUY	$5.24 - $23.4 $38,220 - $170,679	7,294 Added 40.59%	25,264 $591,000
Q1 2020 May 15, 2020	BUY	$4.41 - $9.28 $79,247 - $166,761	17,970 New	17,970 $105,000
Q4 2019 Feb 14, 2020	SELL	$1.45 - $6.73 $23,752 - $110,244	-16,381 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.54 - $4.2 $33,177 - $90,484	-21,544 Reduced 56.81%	16,381 $26,000
Q2 2019 Aug 16, 2019	BUY	$3.84 - $6.4 $6,520 - $10,867	1,698 Added 4.69%	37,925 $154,000
Q2 2019 Aug 14, 2019	BUY	$3.84 - $6.4 $139,111 - $231,852	36,227 New	36,227 $147,000

Others Institutions Holding MRSN

# of Institutions

121

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $215M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Mersana Therapeutics, Inc. Transaction History